VALHALLA, N.Y., Feb. 27, 2020 /PRNewswire/ -- Rectangle Health, a leader in healthcare payment technology announced today it has been awarded a United States Patent for their Practice Management Bridge® technology (Patent No. US 10,503,870 B2).

BEVERLY, Mass., Feb. 27, 2020 /PRNewswire/ -- Medicinal Genomics Corp. (MGC), a pioneer in harnessing cannabis genomics to improve the agricultural productivity, safety, and transparenc

ORLANDO, Fla., Feb. 27, 2020 /PRNewswire/ -- Two Central Florida providers, Orlando Internal Medicine and the Digestive and Liver Center of Florida, are among dozens of physician practices that have selected Andor Health's ThinkAndor™ mobile platform to improve care team communication and collaborati

HONG KONG and SHANGHAI, Feb. 27, 2020 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An", the "Company" or the "Group", HKEX: 02318; SSE: 601318) announced today that five papers related to artificial intelligence (AI) technology in ophthalmic imaging by its smart city's smart health care team (P

LAUSANNE, Switzerland, Feb. 27, 2020 /PRNewswire/ -- Debiopharm (www.debiopharm.com), a Swiss-based, global biopharmaceutical company, today announced that th

The Company's latest U.S. patent is for the Acetylation of Cannabinoids, protecting the production of a cannabinoid-derived prodrug with unique medicinal properties and potential applications in the pharmaceutical industry. VANCOUVER, Feb. 27, 2020 /PRNewswire/ - Nextleaf Solutions Ltd. ("Nextleaf", "OILS", or the "Comp

TORONTO, Feb. 27, 2020 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; OTCQB: SQIDF), today reported its financial and operational results for the three months ended December 31, 2019.SQI is a Toronto-based life sciences and diagnostics company that develops and co

NEW YORK, Feb. 27, 2020 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ("Oramed" or "Company"), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today the pricing of an underwritten public offering of 5,250,000 shares of its common stock at a public offering price of

ALPHARETTA, Ga., Feb. 27, 2020 /PRNewswire/ -- Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, announced its gout prophylaxis product, GLOPERBA® (colchicine), is now commercially available in pharmacies across the United States. The FDA approved GLOPERBA 0.6 mg/5 mL on Jan. 30, 2019

CHARLOTTE, N.C., Feb. 27, 2020 /PRNewswire/ -- For nearly 20 years, the FOR ALL Conference, presented by Atrium Health, has brought together some of the nation's sharpest thought leaders in diversity, inclusion and equity. With a deep panel of experts slated for the two-day event in mid-April, Atrium Health has announced it is making a limited number of scholarships